Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
Tissue Engineering. Part A
|
August 30, 2022
Transcriptomic, Proteomic, and Morphologic Characterization of Healing in Volumetric Muscle Loss
Raphael J Crum, Scott A Johnson, Peng Jiang, et al.
Journal of Biomedical Materials Research. Part A
|
July 23, 2013
Polypropylene surgical mesh coated with extracellular matrix mitigates the host foreign body response
Matthew T Wolf, Christopher A Carruthers, Christopher L Dearth, et al.
European Journal of Medicinal Chemistry
|
July 24, 2021
Discovery and characterization of novel peptide inhibitors of the NRF2/MAFG/DNA ternary complex for the treatment of cancer
Vladimir Simov, Michael D Altman, Elisabetta Bianchi, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Identification of potent inhibitors of the sortilin-progranulin interaction
Shawn J Stachel, Anthony T Ginnetti, Scott A Johnson, et al.
Journal of Medicinal Chemistry
|
February 11, 2026
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma
Deborah S Mortensen, Hunter P Shunatona, Natalie Holmberg-Douglas, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
Tissue Engineering. Part A
|
August 30, 2022
Transcriptomic, Proteomic, and Morphologic Characterization of Healing in Volumetric Muscle Loss
Raphael J Crum, Scott A Johnson, Peng Jiang, et al.
Journal of Biomedical Materials Research. Part A
|
July 23, 2013
Polypropylene surgical mesh coated with extracellular matrix mitigates the host foreign body response
Matthew T Wolf, Christopher A Carruthers, Christopher L Dearth, et al.
European Journal of Medicinal Chemistry
|
July 24, 2021
Discovery and characterization of novel peptide inhibitors of the NRF2/MAFG/DNA ternary complex for the treatment of cancer
Vladimir Simov, Michael D Altman, Elisabetta Bianchi, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Identification of potent inhibitors of the sortilin-progranulin interaction
Shawn J Stachel, Anthony T Ginnetti, Scott A Johnson, et al.
Journal of Medicinal Chemistry
|
February 11, 2026
Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma
Deborah S Mortensen, Hunter P Shunatona, Natalie Holmberg-Douglas, et al.
Page
of 6